{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:26:03Z","timestamp":1793665563724,"version":"4.5.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["chestpulmonary.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST Pulmonary"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.chpulm.2026.100245","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:55:48Z","timestamp":1772178948000},"page":"100245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Pharmacotherapy for Excessive Daytime Sleepiness in OSA"],"prefix":"10.1016","volume":"4","author":[{"given":"Julia L.","family":"Chapman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian Eu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"Grunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-8649","authenticated-orcid":false,"given":"Brendon J.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"164","key":"10.1016\/j.chpulm.2026.100245_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0230-2021","article-title":"Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view","volume":"31","author":"Craig","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100245_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/17476348.2025.2479614","article-title":"Management options for excessive daytime sleepiness in patients with obstructive sleep apnea","volume":"19","author":"Bonsignore","year":"2025","journal-title":"Expert Rev Respir Med"},{"issue":"8","key":"10.1016\/j.chpulm.2026.100245_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/sleep\/29.8.1031","article-title":"Practice parameters for the medical therapy of obstructive sleep apnea","volume":"29","author":"Morgenthaler","year":"2006","journal-title":"Sleep"},{"issue":"11","key":"10.1016\/j.chpulm.2026.100245_bib4","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1164\/rccm.201304-0726ST","article-title":"An official American Thoracic Society Clinical Practice Guideline: sleep apnea, sleepiness, and driving risk in noncommercial drivers. An update of a 1994 statement","volume":"187","author":"Strohl","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chpulm.2026.100245_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2024.101934","article-title":"Evaluating pharmacological treatments for excessive daytime sleepiness in obstructive sleep apnea: a comprehensive network meta-analysis and systematic review","volume":"76","author":"Neshat","year":"2024","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.chpulm.2026.100245_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102843","article-title":"Comparative efficacy, safety and benefit\/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysis","volume":"76","author":"Pepin","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.chpulm.2026.100245_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2024.101997","article-title":"Excessive daytime sleepiness in obstructive sleep apnea: indirect treatment comparison of wake-promoting agents in patients adherent\/nonadherent to primary OSA therapy","volume":"78","author":"Wang","year":"2024","journal-title":"Sleep Med Rev"},{"issue":"6","key":"10.1016\/j.chpulm.2026.100245_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-025-01175-7","article-title":"Comparative efficacy and safety of multiple wake-promoting agents for the treatment of residual sleepiness in obstructive sleep apnea despite continuous positive airway pressure: a systematic review and network meta-analysis of randomized controlled trials","volume":"39","author":"Tanayapong","year":"2025","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.chpulm.2026.100245_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/sleep\/zsad049","article-title":"Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia","volume":"46","author":"Mignot","year":"2023","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100245_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa2301940","article-title":"Oral orexin receptor 2 agonist in narcolepsy type 1","volume":"389","author":"Dauvilliers","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.chpulm.2026.100245_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.sleep.2023.05.001","article-title":"Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP","volume":"107","author":"Bogan","year":"2023","journal-title":"Sleep Med"},{"issue":"19","key":"10.1016\/j.chpulm.2026.100245_bib12","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa2405847","article-title":"Oveporexton, an oral orexin receptor 2-selective agonist, in narcolepsy type 1","volume":"392","author":"Dauvilliers","year":"2025","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.chpulm.2026.100245_bib13","doi-asserted-by":"crossref","first-page":"A363","DOI":"10.1093\/sleep\/zsaf090.0838","article-title":"0838 the orexin 2 receptor agonist alks 2680 in patients with narcolepsy or idiopathic hypersomnia: a phase 1b study","volume":"48","author":"Grunstein","year":"2025","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.chpulm.2026.100245_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/sleep\/zsad224","article-title":"Giving weight to incretin-based pharmacotherapy for obesity-related sleep apnea: a revolution or a pipe dream?","volume":"46","author":"Grunstein","year":"2023","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.chpulm.2026.100245_bib15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.158.12.1333","article-title":"Obesity without sleep apnea is associated with daytime sleepiness","volume":"158","author":"Vgontzas","year":"1998","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.chpulm.2026.100245_bib16","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1210\/jc.2005-0035","article-title":"Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression","volume":"90","author":"Bixler","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.chpulm.2026.100245_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.5665\/sleep.1812","article-title":"Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea\u2014a review","volume":"35","author":"Panossian","year":"2012","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100245_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/ajrccm.163.4.2005036","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea\/hypopnea syndrome","volume":"163","author":"Kingshott","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chpulm.2026.100245_bib19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1164\/ajrccm.164.9.2103032","article-title":"Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea","volume":"164","author":"Pack","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100245_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/sleep\/28.4.464","article-title":"Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea\/hypopnea syndrome","volume":"28","author":"Black","year":"2005","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100245_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2006.06.007","article-title":"Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea\/hypopnea syndrome","volume":"101","author":"Hirshkowitz","year":"2007","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.chpulm.2026.100245_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100245_bib23","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.chest.2020.09.281","article-title":"Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial","volume":"159","author":"P\u00e9pin","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.chpulm.2026.100245_bib24","first-page":"1","article-title":"Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: randomised phase 3 study","volume":"e14373","author":"Dauvilliers","year":"2024","journal-title":"J Sleep Res"},{"issue":"11","key":"10.1016\/j.chpulm.2026.100245_bib25","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201806-1100OC","article-title":"Solriamfetol for excessive sleepiness in obstructive sleep apnea (TONES 3). A randomized controlled trial","volume":"199","author":"Schweitzer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100245_bib26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.chest.2024.10.050","volume":"167","author":"Van Dongen","year":"2025","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chpulm.2026.100245_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1389-9457(03)00108-4","article-title":"Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP","volume":"4","author":"Dinges","year":"2003","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.chpulm.2026.100245_bib28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.chest.2018.11.005","article-title":"Solriamfetol for the treatment of excessive sleepiness in OSA: a placebo-controlled randomized withdrawal study","volume":"155","author":"Strollo","year":"2019","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chpulm.2026.100245_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5664\/jcsm.27648","article-title":"Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment","volume":"5","author":"Weaver","year":"2009","journal-title":"J Clin Sleep Med"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100245_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jsmc.2016.05.005","article-title":"Residual daytime sleepiness in obstructive sleep apnea after continuous positive airway pressure optimization: causes and management","volume":"11","author":"Chapman","year":"2016","journal-title":"Sleep Med Clin"},{"issue":"1","key":"10.1016\/j.chpulm.2026.100245_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11325-007-0137-7","article-title":"Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea","volume":"12","author":"Roth","year":"2008","journal-title":"Sleep Breath"},{"key":"10.1016\/j.chpulm.2026.100245_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2025.02.003","article-title":"Efficacy and safety of pitolisant in residual excessive daytime sleepiness for patients with obstructive sleep apnea adhering to continuous positive airway pressure therapy in the HAROSA studies: an individual patient meta-analytical approach","volume":"129","author":"Testelmans","year":"2025","journal-title":"Sleep Med"},{"issue":"7","key":"10.1016\/j.chpulm.2026.100245_bib33","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1164\/rccm.201712-2439OC","article-title":"Does armodafinil improve driving task performance and weight loss in sleep apnea? A randomized trial","volume":"198","author":"Chapman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chpulm.2026.100245_bib34","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/13993003.01509-2015","article-title":"Modafinil\/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis","volume":"47","author":"Chapman","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chpulm.2026.100245_bib35","doi-asserted-by":"crossref","first-page":"690008","DOI":"10.3389\/fneur.2021.690008","article-title":"Excessive daytime sleepiness in obstructive sleep apnea patients treated with continuous positive airway pressure: data from the European Sleep Apnea Database","volume":"12","author":"Bonsignore","year":"2021","journal-title":"Front Neurol"},{"issue":"12","key":"10.1016\/j.chpulm.2026.100245_bib36","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.5665\/sleep.2226","article-title":"Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the Apnea Positive Pressure Long-term Efficacy Study (APPLES)","volume":"35","author":"Kushida","year":"2012","journal-title":"Sleep"},{"issue":"8","key":"10.1016\/j.chpulm.2026.100245_bib37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1164\/rccm.200908-1307OC","article-title":"Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial","volume":"181","author":"Williams","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100245_bib38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/thoraxjnl-2013-203796","article-title":"Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial","volume":"69","author":"Chapman","year":"2014","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.chpulm.2026.100245_bib39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/thx.2005.050583","article-title":"Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis","volume":"61","author":"Marshall","year":"2006","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.chpulm.2026.100245_bib40","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1164\/rccm.201907-1284OC","article-title":"Pitolisant for daytime sleepiness in patients with obstructive sleep apnea who refuse continuous positive airway pressure treatment. A randomized trial","volume":"201","author":"Dauvilliers","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100245_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13665","article-title":"The orexin story, sleep and sleep disturbances","volume":"31","author":"Pizza","year":"2022","journal-title":"J Sleep Res"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100245_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMe2305779","article-title":"Orexin agonists\u2014two steps forward, one step back","volume":"389","author":"Marshall","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.chpulm.2026.100245_bib43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/sleep\/27.2.194","article-title":"Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions","volume":"27","author":"Veasey","year":"2004","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.chpulm.2026.100245_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5665\/sleep.3306","article-title":"Effects of chronic sleep fragmentation on wake-active neurons and the hypercapnic arousal response","volume":"37","author":"Li","year":"2014","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100245_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.chest.2024.12.032","article-title":"Sleepy heads no more: can we improve cognitive performance with wakefulness promoters?","volume":"167","author":"Chapman","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.chpulm.2026.100245_bib46","article-title":"Efficacy and safety of TAK-861, an oral orexin receptor 2 agonist, in individuals with narcolepsy type 2: results from phase 2 studies","author":"Mignot","year":"2024","journal-title":"J Sleep Res"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100245_bib47","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jcem.85.3.6484","article-title":"Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia","volume":"85","author":"Vgontzas","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100245_bib48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/obr.12498","article-title":"Does intentional weight loss improve daytime sleepiness? A systematic review and meta-analysis","volume":"18","author":"Ng","year":"2017","journal-title":"Obes Rev"},{"issue":"6","key":"10.1016\/j.chpulm.2026.100245_bib49","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.sleh.2022.08.005","article-title":"Daytime sleepiness, addictive-like eating, and obesity sequelae in Black and African American youth with obesity","volume":"8","author":"Pickett","year":"2022","journal-title":"Sleep Health"},{"issue":"2374","key":"10.1016\/j.chpulm.2026.100245_bib50","first-page":"1","article-title":"Association between macronutrient intake and excessive daytime sleepiness: an iso-caloric substitution analysis from the North West Adelaide Health Study","volume":"11","author":"Melaku","year":"2019","journal-title":"Nutrients"},{"issue":"22","key":"10.1016\/j.chpulm.2026.100245_bib51","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/heartjnl-2021-319596","article-title":"Excessive daytime sleepiness: an emerging marker of cardiovascular risk","volume":"108","author":"Bock","year":"2022","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100245_bib52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.orcp.2024.06.003","article-title":"Cardio-metabolic health effects of CPAP treatment for sleep apnoea during weight loss: a randomised controlled pilot trial","volume":"18","author":"Hoyos","year":"2024","journal-title":"Obes Res Clin Pract"},{"issue":"13","key":"10.1016\/j.chpulm.2026.100245_bib53","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"issue":"78","key":"10.1016\/j.chpulm.2026.100245_bib54","first-page":"1","article-title":"An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes","volume":"15","author":"Gomez-Peralta","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.chpulm.2026.100245_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2869.2012.01030.x","article-title":"Exenatide improves excessive daytime sleepiness and wakefulness in obese patients with type 2 diabetes without obstructive sleep apnoea","volume":"22","author":"Idris","year":"2013","journal-title":"J Sleep Res"},{"issue":"4","key":"10.1016\/j.chpulm.2026.100245_bib56","first-page":"1","article-title":"Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis","volume":"48","author":"Li","year":"2024","journal-title":"Sleep"},{"issue":"8","key":"10.1016\/j.chpulm.2026.100245_bib57","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial","volume":"40","author":"Blackman","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.chpulm.2026.100245_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2025.106719","article-title":"Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesity","volume":"134","author":"Kanu","year":"2025","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.chpulm.2026.100245_bib59","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1513\/AnnalsATS.202309-821OC","article-title":"Continuous positive airway pressure but not GLP1-mediated weight loss improves early cardiovascular disease in obstructive sleep apnea: a randomized proof-of-concept study","volume":"21","author":"O\u2019Donnell","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.chpulm.2026.100245_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med."}],"container-title":["CHEST Pulmonary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789226000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949789226000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:34:13Z","timestamp":1793662453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949789226000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2949789226000127"],"URL":"https:\/\/doi.org\/10.1016\/j.chpulm.2026.100245","relation":{},"ISSN":["2949-7892"],"issn-type":[{"value":"2949-7892","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Pharmacotherapy for Excessive Daytime Sleepiness in OSA","name":"articletitle","label":"Article Title"},{"value":"CHEST Pulmonary","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chpulm.2026.100245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100245"}}